Zinc as a paracrine effector in pancreatic islet cell death

98Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

Because of a huge amount of Zn2+ in secretory granules of pancreatic islet β-cells, Zn2+ released in certain conditions might affect the function or survival of islet cells. We studied potential paracrine effects of endogenous Zn2+ on β-cell death. Zn2+ induced insulinoma/islet cell death in a dose-dependent manner. Chelation of released endogenous Zn2+ by CaEDTA significantly decreased streptozotocin (STZ)-induced islet cell death in an in vitro culture system simulating in vivo circumstances but not in the conventional culture system. Zn2+ chelation in vivo by continuous CaEDTA infusion significantly decreased the incidence of diabetes after STZ administration. N-(6-methoxy-quinolyl)-para-toluene-sulfonamide staining revealed that Zn2+ was densely deposited in degenerating islet cells 24 h after STZ treatment, which was decreased by CaEDTA infusion. We show here that Zn2+ is not a passive element for insulin storage but an active participant in islet cell death in certain conditions, which in time might contribute to the development of diabetes in aged people.

Cite

CITATION STYLE

APA

Kim, B. J., Kim, Y. H., Kim, S., Kim, J. W., Koh, J. Y., Oh, S. H., … Lee, M. S. (2000). Zinc as a paracrine effector in pancreatic islet cell death. Diabetes, 49(3), 367–372. https://doi.org/10.2337/diabetes.49.3.367

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free